Semigran Marc
Edgewise Therapeutics, Inc. · Chief Development Officer
Semigran Marc is listed in filings as Chief Development Officer at Edgewise Therapeutics, Inc.. This profile follows SEC Form 4 activity through Dec 27, 2024, including sale activity. Recent filings connect the profile to Edgewise Therapeutics, Inc. (EWTX). The current snapshot covers public activity from Aug 14, 2024 to Dec 27, 2024. Reported amounts are shown as $2.4M to $829.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||